You have 9 free searches left this month | for more free features.

City

Zigong (1)

Condition

HER2-positive Advanced Solid Tumor (1)

Overall Status

Enrolling by invitation (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Hangzhou Adcoris Biopharmacy Co., Ltd (1)

Collaborator

Intervention

zv0203 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

zv0203

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HER2-positive Advanced Solid Tumor Trial in Zigong (ZV0203)

Enrolling by invitation

HER2-positive Advanced Solid Tumor

ZV0203

Zigong, Shandong, China

PKUCare Luzhong Hospital

Jun 14, 2022